BSX · News · 20260812N
Stock Repurchase Program
BOSTON SCIENTIFIC CORP · 2026-08-12 · Importance 64 · Surprise 42 · In source text
Boston Scientific has authorized a $5 billion share repurchase program. Third-party reports cited the authorization alongside the company’s recent quarterly results and institutional ownership data. The reported authorization represents a material capital-allocation commitment relative to the company’s $5.442 billion quarterly revenue base.
Key facts
- Boston Scientific has authorized a $5 billion share buyback program. source
- E. Ohman J or Asset Management AB sold 91.4% of its Boston Scientific shares in the second quarter. source
- Emily Woodworth acquired 2,930 shares of Boston Scientific common stock at $51.19 per share through a 401(k) rebalance on August 11, 2026, increasing her indirect 401(k) holdings to 2,930 shares in addition to her 3,123 directly held shares. source
- Northside Capital Management LLC increased its stake in Boston Scientific by 44.2% in the second quarter to 160,366 shares valued at $6.84 million. source
- Institutional investors hold 89.07% of Boston Scientific's stock. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| cash | negative | committed | — | Boston Scientific has authorized a $5 billion share buyback program. |